Continuation of Research and Development Activities
First written in FY2016-Q2. 29 of 32 entries say "Restated". Latest entry: FY2026-H1.
96 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「R&D expenditure during the interim consolidated period was ¥159 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated period.」
The company continued to state that there were no material changes in its R&D activities, and R&D expenditure for the interim consolidated period was ¥159 million. - FY2025RestatedAnnual report
「The Group intends to pursue R&D actively. It considers ¥1 billion to be a guideline for the annual cap on R&D expenditure and regards these metrics as benchmarks for increasing corporate value.」
The R&D policy of setting ¥1 billion as a guideline for the annual cap and the development policy centered on 2D imager modules and products equipped with them continued. Total R&D expenditure was ¥311 million. - FY2025-H1RestatedAnnual report
「R&D expenditure during the interim consolidated period was ¥155 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated period.」
The company continued to state that there were no material changes in its R&D activities, and R&D expenditure was reported at ¥155 million. - FY2024RestatedAnnual report
「The company considers ¥1 billion to be a guideline for the annual cap on R&D expenditure and regards these metrics as benchmarks for increasing corporate value. During the fiscal year, the Group's R&D activities shifted from developing conventional laser and CCD modules to focusing on 2D imager modules and various scanners and terminal products equipped with those engines, for which market expansion is expected.」
The R&D policy of setting ¥1 billion as a guideline for the annual cap and the development policy centered on 2D imager modules and products equipped with them continued. Total R&D expenditure was ¥301 million. - FY2024-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥177 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥177 million. - FY2024-Q1RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the first quarter was ¥91 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the first quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥91 million. - FY2023RestatedAnnual report
「The company considers ¥1 billion to be a guideline for the annual cap on R&D expenditure and regards these metrics as benchmarks for increasing corporate value. During the fiscal year, the Group's R&D activities shifted from developing conventional laser and CCD modules to focusing on 2D imager modules and various scanners and terminal products equipped with those engines, for which market expansion is expected.」
The R&D policy of setting ¥1 billion as a guideline for the annual cap and the development policy centered on 2D imager modules and products equipped with them continued. Total R&D expenditure was ¥358 million. - FY2023-Q3RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the third quarter was ¥263 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the third quarter.」
The company continued to state that there were no material changes in its R&D activities, and R&D expenditure was reported at ¥263 million. - FY2023-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥182 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥182 million. - FY2023-Q1RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the first quarter was ¥89 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the first quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥89 million. - FY2022RestatedAnnual report
「During the fiscal year, the Group's R&D activities shifted from developing conventional laser and CCD modules to focusing on 2D imager modules and various scanners and terminal products equipped with those engines, for which market expansion is expected. As a result of these R&D activities and other factors, R&D expenditure for the fiscal year totaled ¥379 million, comprising ¥358 million in Japan and ¥20 million in Europe, Asia and other regions.」
The policy of continuing R&D centered on 2D imager modules and products equipped with them continued, and total R&D expenditure was ¥379 million. - FY2022-Q3RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the third quarter was ¥300 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the third quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥300 million. - FY2022-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥202 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was ¥202 million. - FY2021ReframedAnnual report
「To respond to rapid market changes, the company is reviewing its development structure and moving toward a system in which development in Japan focuses on modules and customer needs, while overseas development focuses mainly on standard products such as scanners and handheld terminals. The company aims to reduce the cost of sales and develop products at lower cost and with higher quality.」
In addition to the former R&D policy centered on 2D imager modules, the company indicated a shift to a region-specific development structure, with Japan handling modules and customer-specific development and overseas operations handling standard products. Total R&D expenditure was ¥391 million. - FY2021-Q3RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the third quarter was ¥285 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the third quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was ¥285 million. - FY2021-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥186 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥186 million. - FY2021-Q1RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the first quarter was ¥95 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the first quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥95 million. - FY2020-Q3RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the third quarter was ¥359 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the third quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was ¥359 million. - FY2020-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥236 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was ¥236 million. - FY2020-Q1RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the first quarter was ¥17 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the first quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was reported at ¥17 million. - FY2019RestatedAnnual report
「The company considers ¥1 billion to be a guideline for the annual cap on R&D expenditure and regards these metrics as benchmarks for increasing corporate value. During the fiscal year, the Group's R&D activities shifted from developing conventional laser and CCD modules to focusing on 2D imager modules and various scanners and terminal products equipped with those engines, for which market expansion is expected.」
The R&D policy of setting ¥1 billion as a guideline for the annual cap and focusing on 2D imager modules and products equipped with them, rather than laser and CCD products, continued. Total R&D expenditure was ¥473 million. - FY2019-Q3RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the third quarter was ¥356 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the third quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was reported at ¥356 million. - FY2019-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥232 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was reported at ¥232 million. - FY2019-Q1RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the first quarter was ¥117 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the first quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was reported at ¥117 million. - FY2018R&D focused on CMOS and 2D products, with an annual spending cap set as a guidelineAnnual report
「The company considers ¥1 billion to be a guideline for the annual cap on R&D expenditure and regards these metrics as benchmarks for increasing corporate value. During the fiscal year, the Group's R&D activities shifted from developing conventional laser and CCD modules to focusing on CMOS modules and various scanners and terminal products equipped with CMOS engines, for which market expansion is expected. As a result of these R&D activities and other factors, R&D expenditure for the fiscal year totaled ¥545 million, comprising ¥427 million in Japan and ¥118 million in Europe, Asia and other regions.」
In addition to continuing R&D, the company shifted its development focus to CMOS modules and products equipped with them, set ¥1 billion as a guideline for the annual cap, and reported R&D expenditure of ¥545 million. - FY2018-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥296 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was reported at ¥296 million. - FY2018-Q1RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the first quarter was ¥137 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the first quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was reported at ¥137 million. - FY2017-Q3RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the third quarter was ¥275 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the third quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was reported at ¥275 million. - FY2017-Q2RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥187 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was reported at ¥187 million. - FY2017-Q1RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the first quarter was ¥86 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the first quarter.」
The company continued to state that there were no material changes in the status of its R&D activities. R&D expenditure was reported at ¥86 million. - FY2016-Q3RestatedAnnual report
「R&D expenditure during the cumulative consolidated period for the third quarter was ¥283 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the third quarter.」
The company continued to state that there were no material changes in its R&D activities. R&D expenditure was reported at ¥283 million. - FY2016-Q2First statedAnnual report
「R&D expenditure during the cumulative consolidated period for the second quarter was ¥186 million. There were no material changes in the status of the Group's R&D activities during the cumulative consolidated period for the second quarter.」
R&D expenditure was ¥186 million, with no material changes reported in the status of R&D activities.